JP2006504793A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006504793A5 JP2006504793A5 JP2004571986A JP2004571986A JP2006504793A5 JP 2006504793 A5 JP2006504793 A5 JP 2006504793A5 JP 2004571986 A JP2004571986 A JP 2004571986A JP 2004571986 A JP2004571986 A JP 2004571986A JP 2006504793 A5 JP2006504793 A5 JP 2006504793A5
- Authority
- JP
- Japan
- Prior art keywords
- propyl
- hydroxy
- acetamide
- difluoro
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 aromatic iodides Chemical class 0.000 description 9
- 125000006288 3,5-difluorobenzyl group Chemical group [H]C1=C(F)C([H])=C(C([H])=C1F)C([H])([H])* 0.000 description 8
- 238000000034 method Methods 0.000 description 5
- 125000006239 protecting group Chemical group 0.000 description 5
- VKQBMFKBNMKUBE-UHFFFAOYSA-N 2-iodo-2H-chromene Chemical compound C1=CC=C2C=CC(I)OC2=C1 VKQBMFKBNMKUBE-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 125000006242 amine protecting group Chemical group 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- KLGNPEBEDZARRW-UHFFFAOYSA-N 2-iodo-3,4-dihydro-2h-chromene Chemical compound C1=CC=C2OC(I)CCC2=C1 KLGNPEBEDZARRW-UHFFFAOYSA-N 0.000 description 1
- AJVGILMUMCKDOA-IZZNHLLZSA-N 4-[[(2r,3s)-3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-4-(3-tert-butylphenyl)-n-methylpiperidine-1-carboxamide Chemical compound C1CN(C(=O)NC)CCC1(C=1C=C(C=CC=1)C(C)(C)C)NC[C@@H](O)[C@@H](NC(C)=O)CC1=CC(F)=CC(F)=C1 AJVGILMUMCKDOA-IZZNHLLZSA-N 0.000 description 1
- WKPYEYRMQAMPIL-LOSJGSFVSA-N 4-[[(2r,3s)-3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-4-(3-tert-butylphenyl)piperidine-1-carboxamide Chemical class C([C@H](NC(=O)C)[C@H](O)CNC1(CCN(CC1)C(N)=O)C=1C=C(C=CC=1)C(C)(C)C)C1=CC(F)=CC(F)=C1 WKPYEYRMQAMPIL-LOSJGSFVSA-N 0.000 description 1
- OGRNVANZWCVHPG-UHFFFAOYSA-N CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCC1CNCCC1CC(C)(C)C Chemical compound CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCC1CNCCC1CC(C)(C)C OGRNVANZWCVHPG-UHFFFAOYSA-N 0.000 description 1
- HQCBJRGRUUOUDZ-UHFFFAOYSA-N CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1C1CCN(CC1)S(C)(=O)=O Chemical compound CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1C1CCN(CC1)S(C)(=O)=O HQCBJRGRUUOUDZ-UHFFFAOYSA-N 0.000 description 1
- MNJRMJVGHDFZIK-UHFFFAOYSA-N CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1C1CCNC(=O)C1 Chemical compound CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1C1CCNC(=O)C1 MNJRMJVGHDFZIK-UHFFFAOYSA-N 0.000 description 1
- YHBNQJFQOQDMAX-UHFFFAOYSA-N CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1NS(C)(=O)=O Chemical compound CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1NS(C)(=O)=O YHBNQJFQOQDMAX-UHFFFAOYSA-N 0.000 description 1
- HLUVFENNKGWFJS-UHFFFAOYSA-N CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1S(=O)(=O)Nc1ccccc1 Chemical compound CC(=O)NC(Cc1cc(F)cc(F)c1)C(O)CNCc1cc(CC(C)(C)C)ccc1S(=O)(=O)Nc1ccccc1 HLUVFENNKGWFJS-UHFFFAOYSA-N 0.000 description 1
- BDGHWFBHHVKZDS-ZRRKCSAHSA-N CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(CCCNCC1)c1cccc(c1)C(C)(C)C Chemical compound CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(CCCNCC1)c1cccc(c1)C(C)(C)C BDGHWFBHHVKZDS-ZRRKCSAHSA-N 0.000 description 1
- BELZHPFFRRXWOG-LOSJGSFVSA-N CC(C)c1cccc(c1)C1(CCCCC1)NC[C@@H](O)[C@H](Cc1cc(F)c(O)c(F)c1)NC(C)=O Chemical compound CC(C)c1cccc(c1)C1(CCCCC1)NC[C@@H](O)[C@H](Cc1cc(F)c(O)c(F)c1)NC(C)=O BELZHPFFRRXWOG-LOSJGSFVSA-N 0.000 description 1
- QPHISGKKVAYVBI-RRPNLBNLSA-N CCN1CCC(CC1)(NC[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(C)=O)c1cccc(c1)C(C)C Chemical compound CCN1CCC(CC1)(NC[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(C)=O)c1cccc(c1)C(C)C QPHISGKKVAYVBI-RRPNLBNLSA-N 0.000 description 1
- ALZHZMWJXYTXFK-UHFFFAOYSA-N CNS(=O)(=O)c1ccc(CC(C)(C)C)cc1CNCC(O)C(Cc1cc(F)cc(F)c1)NC(C)=O Chemical compound CNS(=O)(=O)c1ccc(CC(C)(C)C)cc1CNCC(O)C(Cc1cc(F)cc(F)c1)NC(C)=O ALZHZMWJXYTXFK-UHFFFAOYSA-N 0.000 description 1
- GZLQGWNIIWORQV-BJKOFHAPSA-N N-[(2S,3R)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(3-propan-2-yloxyphenyl)oxan-4-yl]amino]butan-2-yl]-2-fluoroacetamide Chemical compound CC(C)Oc1cccc(c1)C1(CCOCC1)NC[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)CF GZLQGWNIIWORQV-BJKOFHAPSA-N 0.000 description 1
- YZYIGLICEOAWTR-RBUKOAKNSA-N N-[(2S,3R)-1-(3,5-difluorophenyl)-4-[2-[2-(2,2-dimethylpropyl)-1,3-thiazol-5-yl]propan-2-ylamino]-3-hydroxybutan-2-yl]acetamide Chemical compound FC=1C=C(C[C@@H]([C@@H](CNC(C)(C)C2=CN=C(S2)CC(C)(C)C)O)NC(C)=O)C=C(C=1)F YZYIGLICEOAWTR-RBUKOAKNSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- USNPOTLKGIASRB-IZZNHLLZSA-N methyl 4-[[(2r,3s)-3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-4-(3-tert-butylphenyl)piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC)CCC1(C=1C=C(C=CC=1)C(C)(C)C)NC[C@@H](O)[C@@H](NC(C)=O)CC1=CC(F)=CC(F)=C1 USNPOTLKGIASRB-IZZNHLLZSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- ZAMBIRFWYNEAHJ-RBUKOAKNSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[2-[2-(2-methylpropyl)-1,3-thiazol-5-yl]propan-2-ylamino]butan-2-yl]acetamide Chemical compound S1C(CC(C)C)=NC=C1C(C)(C)NC[C@@H](O)[C@@H](NC(C)=O)CC1=CC(F)=CC(F)=C1 ZAMBIRFWYNEAHJ-RBUKOAKNSA-N 0.000 description 1
- BPYMYLLVJHEDAE-IZZNHLLZSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[1-methyl-4-(3-propan-2-ylphenyl)piperidin-4-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCN(C)CC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 BPYMYLLVJHEDAE-IZZNHLLZSA-N 0.000 description 1
- ZOLMPEMHCWVHKY-LGOXGGHWSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[1-oxo-4-(3-propan-2-ylphenyl)thian-4-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCS(=O)CC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 ZOLMPEMHCWVHKY-LGOXGGHWSA-N 0.000 description 1
- RCOHUTULLLICIN-LHJLODMPSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[3-(3-propan-2-yloxyphenyl)oxan-3-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)OC1=CC=CC(C2(COCCC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 RCOHUTULLLICIN-LHJLODMPSA-N 0.000 description 1
- HBXRDCZVDPEBHE-LHJLODMPSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[3-(3-propan-2-ylphenyl)oxan-3-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(COCCC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 HBXRDCZVDPEBHE-LHJLODMPSA-N 0.000 description 1
- UOKUNDFNXUGJJC-LOSJGSFVSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(3-propan-2-yloxyphenyl)oxan-4-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)OC1=CC=CC(C2(CCOCC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 UOKUNDFNXUGJJC-LOSJGSFVSA-N 0.000 description 1
- QEFGGKHLYDBREI-LOSJGSFVSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(3-propan-2-ylphenyl)-1-(2,2,2-trifluoroacetyl)piperidin-4-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCN(CC2)C(=O)C(F)(F)F)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 QEFGGKHLYDBREI-LOSJGSFVSA-N 0.000 description 1
- AMRFQGHEIBTPHM-LOSJGSFVSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(3-propan-2-ylphenyl)piperidin-4-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCNCC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 AMRFQGHEIBTPHM-LOSJGSFVSA-N 0.000 description 1
- CXZXEYUJQRWHPB-LOSJGSFVSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(3-propan-2-ylphenyl)thian-4-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCSCC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 CXZXEYUJQRWHPB-LOSJGSFVSA-N 0.000 description 1
- RSZSSBCSMRWEFY-XZOQPEGZSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[2-[3-(2,2-dimethylpropyl)phenyl]propan-2-ylamino]-3-hydroxybutan-2-yl]-2-fluoroacetamide Chemical compound CC(C)(C)CC1=CC=CC(C(C)(C)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(=O)CF)=C1 RSZSSBCSMRWEFY-XZOQPEGZSA-N 0.000 description 1
- JMLHZBBCZLPDFD-LOSJGSFVSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[1,1-dioxo-4-(3-propan-2-ylphenyl)thian-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCS(=O)(=O)CC2)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 JMLHZBBCZLPDFD-LOSJGSFVSA-N 0.000 description 1
- WAHIMGHKKYULHH-RRPNLBNLSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[1-ethylsulfonyl-4-(3-propan-2-ylphenyl)piperidin-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1CN(S(=O)(=O)CC)CCC1(C=1C=C(C=CC=1)C(C)C)NC[C@@H](O)[C@@H](NC(C)=O)CC1=CC(F)=CC(F)=C1 WAHIMGHKKYULHH-RRPNLBNLSA-N 0.000 description 1
- NRNBKONHSZAGCO-IZZNHLLZSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[1-formyl-4-(3-propan-2-ylphenyl)piperidin-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCN(CC2)C=O)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 NRNBKONHSZAGCO-IZZNHLLZSA-N 0.000 description 1
- WTTXUEPBGFULOK-ATTQYFOMSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[6-(2,2-dimethylpropyl)-3,4-dihydro-2h-chromen-4-yl]amino]-3-hydroxybutan-2-yl]-2-fluoroacetamide Chemical compound C([C@@H]([C@H](O)CNC1CCOC2=CC=C(C=C21)CC(C)(C)C)NC(=O)CF)C1=CC(F)=CC(F)=C1 WTTXUEPBGFULOK-ATTQYFOMSA-N 0.000 description 1
- UEJHCNVNHBILHU-YIKNKFAXSA-N n-[(2s,3r)-4-[[(4r)-4-(3-tert-butylphenyl)-1-methylsulfonylazepan-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@]1(CCN(CCC1)S(C)(=O)=O)C=1C=C(C=CC=1)C(C)(C)C)C1=CC(F)=CC(F)=C1 UEJHCNVNHBILHU-YIKNKFAXSA-N 0.000 description 1
- UEJHCNVNHBILHU-GKRYNVPLSA-N n-[(2s,3r)-4-[[(4s)-4-(3-tert-butylphenyl)-1-methylsulfonylazepan-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@]1(CCN(CCC1)S(C)(=O)=O)C=1C=C(C=CC=1)C(C)(C)C)C1=CC(F)=CC(F)=C1 UEJHCNVNHBILHU-GKRYNVPLSA-N 0.000 description 1
- BDGHWFBHHVKZDS-REUBFRLUSA-N n-[(2s,3r)-4-[[(4s)-4-(3-tert-butylphenyl)azepan-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@]1(CCNCCC1)C=1C=C(C=CC=1)C(C)(C)C)C1=CC(F)=CC(F)=C1 BDGHWFBHHVKZDS-REUBFRLUSA-N 0.000 description 1
- MZYUFFBIBGWZPG-RRPNLBNLSA-N n-[(2s,3r)-4-[[1-acetyl-4-(3-propan-2-ylphenyl)piperidin-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCN(CC2)C(C)=O)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 MZYUFFBIBGWZPG-RRPNLBNLSA-N 0.000 description 1
- YFVOANNZUKFDLA-RRPNLBNLSA-N n-[(2s,3r)-4-[[4-(3-tert-butylphenyl)-1-ethylsulfonylpiperidin-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1CN(S(=O)(=O)CC)CCC1(C=1C=C(C=CC=1)C(C)(C)C)NC[C@@H](O)[C@@H](NC(C)=O)CC1=CC(F)=CC(F)=C1 YFVOANNZUKFDLA-RRPNLBNLSA-N 0.000 description 1
- VTOCROULHXLCTO-IZZNHLLZSA-N n-[(2s,3r)-4-[[4-(3-tert-butylphenyl)-1-methylsulfonylpiperidin-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CNC1(CCN(CC1)S(C)(=O)=O)C=1C=C(C=CC=1)C(C)(C)C)C1=CC(F)=CC(F)=C1 VTOCROULHXLCTO-IZZNHLLZSA-N 0.000 description 1
- ZZNPZEDXBOXPKP-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-hydroxy-2-methyl-6-propan-2-yl-1,3-dihydroinden-1-yl)amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(C)(O)C1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 ZZNPZEDXBOXPKP-UHFFFAOYSA-N 0.000 description 1
- UBVSMOCCQXRAEM-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-oxo-5-propan-2-yl-1,3-dihydroindol-3-yl)amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2NC(=O)C1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 UBVSMOCCQXRAEM-UHFFFAOYSA-N 0.000 description 1
- UMUKWUJRBWTHPM-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-oxo-6-propan-2-yl-1,3-dihydroinden-1-yl)amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(=O)C1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 UMUKWUJRBWTHPM-UHFFFAOYSA-N 0.000 description 1
- SIRXEBJNBLTORW-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-oxo-6-propan-2-yl-3,4-dihydro-1h-quinolin-4-yl)amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2NC(=O)CC1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 SIRXEBJNBLTORW-UHFFFAOYSA-N 0.000 description 1
- FVCGLJGTGULRQK-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[(3-hydroxy-3-methyl-7-propan-2-yl-2,4-dihydro-1h-naphthalen-1-yl)amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(C)(O)CC1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 FVCGLJGTGULRQK-UHFFFAOYSA-N 0.000 description 1
- INDOQRFKUMFKIU-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[(3-oxo-7-propan-2-yl-2,4-dihydro-1h-naphthalen-1-yl)amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(=O)CC1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 INDOQRFKUMFKIU-UHFFFAOYSA-N 0.000 description 1
- BQZAWEGAYUNKOO-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[1-(3-propan-2-ylphenyl)cyclobutyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCC2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 BQZAWEGAYUNKOO-UHFFFAOYSA-N 0.000 description 1
- JXXJIXOVFJAARM-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[1-(3-propan-2-ylphenyl)cyclopentyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CCCC2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 JXXJIXOVFJAARM-UHFFFAOYSA-N 0.000 description 1
- SFUTUZARGZOSMO-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[2,2,4,4-tetramethyl-3-oxo-1-(3-propan-2-ylphenyl)cyclobutyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(NCC(O)C(CC=3C=C(F)C=C(F)C=3)NC(C)=O)C(C(=O)C2(C)C)(C)C)=C1 SFUTUZARGZOSMO-UHFFFAOYSA-N 0.000 description 1
- STIZOSVVIKQECX-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[2-(4-methylpiperazin-1-yl)-5-(2-methylpropyl)phenyl]methylamino]butan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1N1CCN(C)CC1 STIZOSVVIKQECX-UHFFFAOYSA-N 0.000 description 1
- QYGNWJKMQGQSNW-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[2-(methanesulfonamido)-6-propan-2-yl-2,3-dihydro-1h-inden-1-yl]amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(NS(C)(=O)=O)C1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 QYGNWJKMQGQSNW-UHFFFAOYSA-N 0.000 description 1
- KYQIWSAEJHPQLJ-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[2-methyl-5-(3-propan-2-ylphenyl)-1,3,3a,4,6,6a-hexahydrocyclopenta[c]pyrrol-5-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CN(C)CC3C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 KYQIWSAEJHPQLJ-UHFFFAOYSA-N 0.000 description 1
- IJMJBLQMUMMSOY-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[2-methylsulfonyl-5-(3-propan-2-ylphenyl)-1,3,3a,4,6,6a-hexahydrocyclopenta[c]pyrrol-5-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CN(CC3C2)S(C)(=O)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 IJMJBLQMUMMSOY-UHFFFAOYSA-N 0.000 description 1
- KFBFMCLJWUAMHJ-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[3-(3-propan-2-ylphenyl)-3-bicyclo[3.1.0]hexanyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CC3C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 KFBFMCLJWUAMHJ-UHFFFAOYSA-N 0.000 description 1
- OKMBMSPRRZXOOG-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[3-(3-propan-2-ylphenyl)-6-azabicyclo[3.1.0]hexan-3-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3NC3C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 OKMBMSPRRZXOOG-UHFFFAOYSA-N 0.000 description 1
- SYYRWCZTAHHNLX-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[3-(methanesulfonamido)-7-propan-2-yl-1,2,3,4-tetrahydronaphthalen-1-yl]amino]butan-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(NS(C)(=O)=O)CC1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 SYYRWCZTAHHNLX-UHFFFAOYSA-N 0.000 description 1
- AMNIBXBOTXLWNG-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[3-hydroxy-2,2,4,4-tetramethyl-1-(3-propan-2-ylphenyl)cyclobutyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(NCC(O)C(CC=3C=C(F)C=C(F)C=3)NC(C)=O)C(C(O)C2(C)C)(C)C)=C1 AMNIBXBOTXLWNG-UHFFFAOYSA-N 0.000 description 1
- WWSIXWQSRQGPIB-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(methanesulfonamido)-2-(3-propan-2-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CCC(C2)NS(C)(=O)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 WWSIXWQSRQGPIB-UHFFFAOYSA-N 0.000 description 1
- MCVGTLNVYCTBQD-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-(methanesulfonamido)-2-(3-propan-2-ylphenyl)cyclopentyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(C2)NS(C)(=O)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 MCVGTLNVYCTBQD-UHFFFAOYSA-N 0.000 description 1
- PNEHHRPUXHLWIL-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-hydroxy-4-methyl-2-(3-propan-2-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CCC(C)(O)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 PNEHHRPUXHLWIL-UHFFFAOYSA-N 0.000 description 1
- YJQCBGQQDNKFOY-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-hydroxy-4-methyl-2-(3-propan-2-ylphenyl)cyclopentyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(C)(O)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 YJQCBGQQDNKFOY-UHFFFAOYSA-N 0.000 description 1
- FPZNOHWQBMEFGS-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-oxo-2-(3-propan-2-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CCC(=O)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 FPZNOHWQBMEFGS-UHFFFAOYSA-N 0.000 description 1
- NTPLNNHUKSTTDM-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[4-oxo-2-(3-propan-2-ylphenyl)cyclopentyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(=O)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 NTPLNNHUKSTTDM-UHFFFAOYSA-N 0.000 description 1
- FYCZPMRSVDMGFG-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-(2-methylpropyl)-2-(1-methylsulfonylpiperidin-4-yl)phenyl]methylamino]butan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1C1CCN(S(C)(=O)=O)CC1 FYCZPMRSVDMGFG-UHFFFAOYSA-N 0.000 description 1
- LOALCEARDBJJNJ-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-(2-methylpropyl)-2-(4-methylsulfonylpiperazin-1-yl)phenyl]methylamino]butan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1N1CCN(S(C)(=O)=O)CC1 LOALCEARDBJJNJ-UHFFFAOYSA-N 0.000 description 1
- VISUXJMHQBCLES-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-(2-methylpropyl)-2-piperazin-1-ylphenyl]methylamino]butan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1N1CCNCC1 VISUXJMHQBCLES-UHFFFAOYSA-N 0.000 description 1
- XEABYXKSZQOVPN-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-(2-methylpropyl)-2-piperidin-4-ylphenyl]methylamino]butan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1C1CCNCC1 XEABYXKSZQOVPN-UHFFFAOYSA-N 0.000 description 1
- YQKVJONRNKKMIO-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-(3-propan-2-ylphenyl)-2,3,3a,4,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-5-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CNCC3C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 YQKVJONRNKKMIO-UHFFFAOYSA-N 0.000 description 1
- KBGJXSCIBIJIKW-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-(methanesulfonamido)-2-(3-propan-2-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(CC2)NS(C)(=O)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 KBGJXSCIBIJIKW-UHFFFAOYSA-N 0.000 description 1
- HKMNMGHUVGDFGK-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-hydroxy-2-(3-propan-2-ylphenyl)-3,3a,4,5,6,6a-hexahydro-1h-pentalen-2-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CC(O)CC3C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 HKMNMGHUVGDFGK-UHFFFAOYSA-N 0.000 description 1
- ZYBXLYIJHIXSBZ-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-hydroxy-3a,6a-dimethyl-2-(3-propan-2-ylphenyl)-3,4,5,6-tetrahydro-1h-pentalen-2-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3(C)CC(O)CC3(C)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 ZYBXLYIJHIXSBZ-UHFFFAOYSA-N 0.000 description 1
- FRFASWYMLHVCRP-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-hydroxy-5-methyl-2-(3-propan-2-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(C)(O)CC2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 FRFASWYMLHVCRP-UHFFFAOYSA-N 0.000 description 1
- DLJHMECJYUXPEV-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-oxo-2-(3-propan-2-ylphenyl)-1,3,3a,4,6,6a-hexahydropentalen-2-yl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CC(=O)CC3C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 DLJHMECJYUXPEV-UHFFFAOYSA-N 0.000 description 1
- WMZHCEFTKBQBCO-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[5-oxo-2-(3-propan-2-ylphenyl)cyclohexyl]amino]butan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(=O)CC2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 WMZHCEFTKBQBCO-UHFFFAOYSA-N 0.000 description 1
- KZFDRYFNZRRUMA-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-3-hydroxy-4-[[6-(2-methylpropyl)-2,2-dioxo-3,4-dihydro-1h-2$l^{6},1-benzothiazin-4-yl]amino]butan-2-yl]acetamide Chemical compound C12=CC(CC(C)C)=CC=C2NS(=O)(=O)CC1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 KZFDRYFNZRRUMA-UHFFFAOYSA-N 0.000 description 1
- AZVYDHBLFKBPEN-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[4-(2,2-dimethylpropyl)-1-methylsulfonylpiperidin-3-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1N(S(C)(=O)=O)CCC(CC(C)(C)C)C1NCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 AZVYDHBLFKBPEN-UHFFFAOYSA-N 0.000 description 1
- QUWORKFGXXZWCA-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[4-(2,2-dimethylpropyl)-1-methylsulfonylpiperidin-3-yl]methylamino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1N(S(C)(=O)=O)CCC(CC(C)(C)C)C1CNCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 QUWORKFGXXZWCA-UHFFFAOYSA-N 0.000 description 1
- ZVYWGVFNZNSDMG-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[4-(2,2-dimethylpropyl)piperidin-3-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1NCCC(CC(C)(C)C)C1NCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 ZVYWGVFNZNSDMG-UHFFFAOYSA-N 0.000 description 1
- DGOKCVVNOCHGBR-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[4-(2,2-dimethylpropyl)pyridin-3-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C=1N=CC=C(CC(C)(C)C)C=1NCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 DGOKCVVNOCHGBR-UHFFFAOYSA-N 0.000 description 1
- VRKYQXBOKHWOMB-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[4-(2,2-dimethylpropyl)pyridin-3-yl]methylamino]-3-hydroxybutan-2-yl]acetamide Chemical compound C=1N=CC=C(CC(C)(C)C)C=1CNCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 VRKYQXBOKHWOMB-UHFFFAOYSA-N 0.000 description 1
- OPRPENFGJILLLT-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[5-(2,2-dimethylpropyl)-2-(1-methyl-2-oxopiperidin-4-yl)phenyl]methylamino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1C(=O)N(C)CCC1C1=CC=C(CC(C)(C)C)C=C1CNCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 OPRPENFGJILLLT-UHFFFAOYSA-N 0.000 description 1
- WGRLZYXWVBASLF-UHFFFAOYSA-N n-[1-(3,5-difluorophenyl)-4-[[5-(2,2-dimethylpropyl)-2-piperidin-4-ylphenyl]methylamino]-3-hydroxybutan-2-yl]acetamide Chemical compound C=1C(CC(C)(C)C)=CC=C(C2CCNCC2)C=1CNCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 WGRLZYXWVBASLF-UHFFFAOYSA-N 0.000 description 1
- HMHYSWAGWIKTDS-UHFFFAOYSA-N n-[1-[[3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-6-propan-2-yl-2,3-dihydro-1h-inden-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(NC(C)=O)C1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 HMHYSWAGWIKTDS-UHFFFAOYSA-N 0.000 description 1
- SLTZYFLBGNBXKX-UHFFFAOYSA-N n-[3-[[3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-4-(3-propan-2-ylphenyl)cyclohexyl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(CC2)NC(C)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 SLTZYFLBGNBXKX-UHFFFAOYSA-N 0.000 description 1
- GKOAJFKIKLZHSB-UHFFFAOYSA-N n-[3-[[3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-4-(3-propan-2-ylphenyl)cyclopentyl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CC(C2)NC(C)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 GKOAJFKIKLZHSB-UHFFFAOYSA-N 0.000 description 1
- ZNSOJFOOSSPIRM-UHFFFAOYSA-N n-[4-[(5-tert-butyl-2-imidazol-1-ylphenyl)methylamino]-1-(3,5-difluorophenyl)-3,5-dihydroxypentan-2-yl]acetamide Chemical compound C=1C(C(C)(C)C)=CC=C(N2C=NC=C2)C=1CNC(CO)C(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 ZNSOJFOOSSPIRM-UHFFFAOYSA-N 0.000 description 1
- HFJUOOVOFIUFIU-UHFFFAOYSA-N n-[4-[(5-tert-butyl-2-imidazol-1-ylphenyl)methylamino]-1-(3,5-difluorophenyl)-3-hydroxypentan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)C(C)NCC1=CC(C(C)(C)C)=CC=C1N1C=CN=C1 HFJUOOVOFIUFIU-UHFFFAOYSA-N 0.000 description 1
- TVOOEAVUFFLBFC-UHFFFAOYSA-N n-[4-[[1-acetyl-4-(2,2-dimethylpropyl)piperidin-3-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1N(C(C)=O)CCC(CC(C)(C)C)C1NCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 TVOOEAVUFFLBFC-UHFFFAOYSA-N 0.000 description 1
- NQCZCQHXYBBUEF-UHFFFAOYSA-N n-[4-[[1-acetyl-4-(2,2-dimethylpropyl)piperidin-3-yl]methylamino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1N(C(C)=O)CCC(CC(C)(C)C)C1CNCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 NQCZCQHXYBBUEF-UHFFFAOYSA-N 0.000 description 1
- UTIFAYOZAXRXPV-UHFFFAOYSA-N n-[4-[[2-(1-acetylpiperidin-4-yl)-5-(2,2-dimethylpropyl)phenyl]methylamino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C=1C(CC(C)(C)C)=CC=C(C2CCN(CC2)C(C)=O)C=1CNCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 UTIFAYOZAXRXPV-UHFFFAOYSA-N 0.000 description 1
- GGZHKYGJJHMOSH-UHFFFAOYSA-N n-[4-[[2-(1-acetylpiperidin-4-yl)-5-(2-methylpropyl)phenyl]methylamino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1C1CCN(C(C)=O)CC1 GGZHKYGJJHMOSH-UHFFFAOYSA-N 0.000 description 1
- LMVVFWSUXYBAIL-UHFFFAOYSA-N n-[4-[[2-(4-acetylpiperazin-1-yl)-5-(2-methylpropyl)phenyl]methylamino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)CNCC1=CC(CC(C)C)=CC=C1N1CCN(C(C)=O)CC1 LMVVFWSUXYBAIL-UHFFFAOYSA-N 0.000 description 1
- SMYFTHIPHZZLLN-UHFFFAOYSA-N n-[4-[[2-(benzenesulfonamido)-5-(2,2-dimethylpropyl)phenyl]methylamino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C=1C(CC(C)(C)C)=CC=C(NS(=O)(=O)C=2C=CC=CC=2)C=1CNCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 SMYFTHIPHZZLLN-UHFFFAOYSA-N 0.000 description 1
- CMHAZPPILXQAQO-UHFFFAOYSA-N n-[4-[[2-acetyl-5-(3-propan-2-ylphenyl)-1,3,3a,4,6,6a-hexahydrocyclopenta[c]pyrrol-5-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3CN(CC3C2)C(C)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 CMHAZPPILXQAQO-UHFFFAOYSA-N 0.000 description 1
- JNTIZYXXWKZDHZ-UHFFFAOYSA-N n-[4-[[3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-3-(3-propan-2-ylphenyl)cyclohexyl]acetamide Chemical compound CC(C)C1=CC=CC(C2C(CCC(C2)NC(C)=O)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 JNTIZYXXWKZDHZ-UHFFFAOYSA-N 0.000 description 1
- FVJNGSKQSVMTDX-UHFFFAOYSA-N n-[4-[[3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]-6-propan-2-yl-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide Chemical compound C12=CC(C(C)C)=CC=C2CC(NC(C)=O)CC1NCC(O)C(NC(C)=O)CC1=CC(F)=CC(F)=C1 FVJNGSKQSVMTDX-UHFFFAOYSA-N 0.000 description 1
- KTYFGOSMEGKUKH-UHFFFAOYSA-N n-[4-[[3a,6a-dimethyl-5-oxo-2-(3-propan-2-ylphenyl)-1,3,4,6-tetrahydropentalen-2-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3(C)CC(=O)CC3(C)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 KTYFGOSMEGKUKH-UHFFFAOYSA-N 0.000 description 1
- GWAPFOYYGXMBMH-UHFFFAOYSA-N n-[4-[[4-(3-tert-butylphenyl)oxan-4-yl]amino]-1-(3,5-difluorophenyl)-3,5-dihydroxypentan-2-yl]acetamide Chemical compound C1COCCC1(C=1C=C(C=CC=1)C(C)(C)C)NC(CO)C(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 GWAPFOYYGXMBMH-UHFFFAOYSA-N 0.000 description 1
- HDMDKNWBBJEOCB-UHFFFAOYSA-N n-[4-[[4-(3-tert-butylphenyl)oxan-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1COCCC1(C=1C=C(C=CC=1)C(C)(C)C)NCC(O)C(NC(=O)C)CC1=CC(F)=CC(F)=C1 HDMDKNWBBJEOCB-UHFFFAOYSA-N 0.000 description 1
- UXTXWUSOMKQZFS-UHFFFAOYSA-N n-[4-[[4-(3-tert-butylphenyl)oxan-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxypentan-2-yl]acetamide Chemical compound C=1C(F)=CC(F)=CC=1CC(NC(C)=O)C(O)C(C)NC1(C=2C=C(C=CC=2)C(C)(C)C)CCOCC1 UXTXWUSOMKQZFS-UHFFFAOYSA-N 0.000 description 1
- LVRREEDPVDGRTD-UHFFFAOYSA-N n-[4-[[6-(2,2-dimethylpropyl)-3,4-dihydro-2h-chromen-4-yl]amino]-1-(3-fluoro-4-hydroxyphenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1COC2=CC=C(CC(C)(C)C)C=C2C1NCC(O)C(NC(=O)C)CC1=CC=C(O)C(F)=C1 LVRREEDPVDGRTD-UHFFFAOYSA-N 0.000 description 1
- IJYFXCLFIWWIDE-UHFFFAOYSA-N n-[4-[[6-(2,2-dimethylpropyl)-3,4-dihydro-2h-chromen-4-yl]amino]-3-hydroxy-1-(5-hydroxypyridin-2-yl)butan-2-yl]acetamide Chemical compound C1COC2=CC=C(CC(C)(C)C)C=C2C1NCC(O)C(NC(=O)C)CC1=CC=C(O)C=N1 IJYFXCLFIWWIDE-UHFFFAOYSA-N 0.000 description 1
- ASEBRBPOHPQWKD-UHFFFAOYSA-N n-[4-[[6-acetyl-3-(3-propan-2-ylphenyl)-6-azabicyclo[3.1.0]hexan-3-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound CC(C)C1=CC=CC(C2(CC3C(N3C(C)=O)C2)NCC(O)C(CC=2C=C(F)C=C(F)C=2)NC(C)=O)=C1 ASEBRBPOHPQWKD-UHFFFAOYSA-N 0.000 description 1
- KSUBPNQRUAPZAN-UHFFFAOYSA-N n-[4-[[7-(2,2-dimethylpropyl)-1,2,3,4-tetrahydronaphthalen-1-yl]amino]-1-(3-fluoro-4-hydroxyphenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1CCC2=CC=C(CC(C)(C)C)C=C2C1NCC(O)C(NC(=O)C)CC1=CC=C(O)C(F)=C1 KSUBPNQRUAPZAN-UHFFFAOYSA-N 0.000 description 1
- JLZHHXVXYUTXQY-UHFFFAOYSA-N n-[4-[[7-(2,2-dimethylpropyl)-1,2,3,4-tetrahydronaphthalen-1-yl]amino]-3-hydroxy-1-(5-hydroxypyridin-2-yl)butan-2-yl]acetamide Chemical compound C1CCC2=CC=C(CC(C)(C)C)C=C2C1NCC(O)C(NC(=O)C)CC1=CC=C(O)C=N1 JLZHHXVXYUTXQY-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40945302P | 2002-09-10 | 2002-09-10 | |
| US45223103P | 2003-03-05 | 2003-03-05 | |
| US49175703P | 2003-08-01 | 2003-08-01 | |
| PCT/US2003/028503 WO2004024081A2 (en) | 2002-09-10 | 2003-09-10 | Acetyl 2-hydroxy-1,3 diaminoalkanes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010273586A Division JP2011084568A (ja) | 2002-09-10 | 2010-12-08 | アセチル２−ヒドロオキシ−１，３−ダイアミノアルカン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006504793A JP2006504793A (ja) | 2006-02-09 |
| JP2006504793A5 true JP2006504793A5 (enExample) | 2011-02-10 |
Family
ID=31999211
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004571986A Pending JP2006504793A (ja) | 2002-09-10 | 2003-09-10 | アセチル２−ヒドロオキシ−１，３−ダイアミノアルカン |
| JP2010273586A Pending JP2011084568A (ja) | 2002-09-10 | 2010-12-08 | アセチル２−ヒドロオキシ−１，３−ダイアミノアルカン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010273586A Pending JP2011084568A (ja) | 2002-09-10 | 2010-12-08 | アセチル２−ヒドロオキシ−１，３−ダイアミノアルカン |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US7244725B2 (enExample) |
| EP (1) | EP1565443A4 (enExample) |
| JP (2) | JP2006504793A (enExample) |
| KR (1) | KR20060057520A (enExample) |
| AR (1) | AR043679A1 (enExample) |
| AU (1) | AU2003267132A1 (enExample) |
| BR (1) | BR0314188A (enExample) |
| CA (1) | CA2498248A1 (enExample) |
| EA (1) | EA009196B1 (enExample) |
| EC (1) | ECSP055696A (enExample) |
| GE (1) | GEP20074166B (enExample) |
| IS (1) | IS7732A (enExample) |
| MA (1) | MA27472A1 (enExample) |
| MX (1) | MXPA05002695A (enExample) |
| NO (1) | NO20051239L (enExample) |
| NZ (1) | NZ539095A (enExample) |
| OA (1) | OA12919A (enExample) |
| PE (1) | PE20041079A1 (enExample) |
| PL (1) | PL376511A1 (enExample) |
| TW (1) | TWI336320B (enExample) |
| UA (1) | UA84407C2 (enExample) |
| UY (1) | UY27967A1 (enExample) |
| WO (1) | WO2004024081A2 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004050609A1 (en) * | 2002-11-27 | 2004-06-17 | Elan Pharmaceutical, Inc. | Substituted ureas and carbamates |
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| TW200505418A (en) * | 2003-04-21 | 2005-02-16 | Elan Pharm Inc | Phenacyl 2-hydroxy-3-diaminoalkanes |
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| JP2007522129A (ja) * | 2004-01-21 | 2007-08-09 | エラン ファーマシューティカルズ，インコーポレイテッド | アスパラギン酸プロテアーゼ阻害薬を用いるアミロイドーシスの処置方法 |
| CA2558249A1 (en) * | 2004-03-09 | 2005-09-22 | Elan Pharmaceuticals, Inc. | Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| EP1734961A2 (en) * | 2004-03-09 | 2006-12-27 | Elan Pharmaceuticals, Inc. | Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors |
| US20050239836A1 (en) | 2004-03-09 | 2005-10-27 | Varghese John | Substituted hydroxyethylamine aspartyl protease inhibitors |
| CA2558036A1 (en) * | 2004-03-09 | 2005-09-22 | Elan Pharmaceuticals, Inc. | Substituted hydroxyethylamine aspartyl protease inhibitors |
| US7618978B2 (en) | 2004-04-22 | 2009-11-17 | Eli Lilly And Company | Amides as BACE inhibitors |
| US7585885B2 (en) | 2004-04-22 | 2009-09-08 | Eli Lilly And Company | Pyrrolidine derivatives useful as BACE inhibitors |
| EP1773756A2 (en) | 2004-07-09 | 2007-04-18 | Elan Pharmaceuticals, Inc. | Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| US20060128715A1 (en) * | 2004-07-09 | 2006-06-15 | Jennifer Sealy | Oxime derivative hydroxyethylamine aspartyl-protease inhibitors |
| PE20060692A1 (es) * | 2004-09-21 | 2006-07-19 | Lilly Co Eli | Inhibidores bace |
| JP2008530079A (ja) * | 2005-02-14 | 2008-08-07 | ファイザー・プロダクツ・インク | 置換ヒドロキシエチルアミン |
| US7893267B2 (en) * | 2005-03-14 | 2011-02-22 | High Point Pharmaceuticals, Llc | Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors |
| JP2008535863A (ja) | 2005-04-08 | 2008-09-04 | コメンティス，インコーポレーテッド | β−セクレターゼ活性を阻害する化合物およびその使用方法 |
| WO2007047305A1 (en) | 2005-10-12 | 2007-04-26 | Elan Pharmaceuticals, Inc. | Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
| CA2624904A1 (en) * | 2005-10-12 | 2007-04-26 | Elan Pharmaceuticals, Inc. | Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| US7838676B2 (en) | 2005-11-21 | 2010-11-23 | Amgen Inc. | Beta-secretase modulators and methods of use |
| US7745484B2 (en) | 2005-11-21 | 2010-06-29 | Amgen Inc. | Beta-secretase modulators and methods of use |
| US7872009B2 (en) | 2005-11-21 | 2011-01-18 | Amgen Inc. | Beta-Secretase modulators and methods of use |
| WO2007061670A1 (en) | 2005-11-21 | 2007-05-31 | Amgen Inc. | Beta-secretase modulators and methods of use |
| EP1957448A1 (en) * | 2005-11-22 | 2008-08-20 | Pfizer Products Inc. | Substituted azacycloalkanes useful for treating cns conditions |
| BRPI0719336A2 (pt) * | 2006-11-23 | 2014-02-04 | Novartis Ag | Derivados de 2-hidróxi-1,3-diaminopropano |
| TW200901991A (en) | 2007-05-25 | 2009-01-16 | Amgen Inc | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| CA2687608C (en) | 2007-05-25 | 2013-07-02 | Amgen Inc. | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| US7803809B2 (en) | 2008-11-12 | 2010-09-28 | Amgen Inc. | Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use |
| DE102008039083A1 (de) | 2008-08-21 | 2010-02-25 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 5-Aminopyrazole und ihre Verwendung |
| MX2011002705A (es) * | 2008-09-11 | 2011-09-09 | Amgen Inc | Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso. |
| EP2504330A1 (en) | 2009-11-23 | 2012-10-03 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| US9296698B2 (en) | 2009-11-23 | 2016-03-29 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| CA2788363A1 (en) | 2010-01-19 | 2011-07-28 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| ES2450568T3 (es) | 2010-03-15 | 2014-03-25 | Amgen Inc. | Compuestos espiero de amino-dihidrooxazina y amino-dihidrotiazina como moduladores de beta-secretasa y su uso médico |
| MX2012010658A (es) | 2010-03-15 | 2012-12-05 | Amgen Inc | Compuestos de anillo espiro tetraciclico como moduladores de beta-secretasa. |
| WO2012109165A1 (en) | 2011-02-07 | 2012-08-16 | Amgen Inc. | 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use |
| WO2013044092A1 (en) | 2011-09-21 | 2013-03-28 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| US9725469B2 (en) | 2012-11-15 | 2017-08-08 | Amgen, Inc. | Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| EP3490607A4 (en) | 2016-07-29 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | COMPOUNDS AND COMPOSITIONS, AND USES THEREOF |
| SG11202000669VA (en) | 2017-08-02 | 2020-02-27 | Sunovion Pharmaceuticals Inc | Isochroman compounds and uses thereof |
| US11760701B2 (en) | 2018-02-27 | 2023-09-19 | The Research Foundation For The State University Of New Yrok | Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same |
| PL243516B1 (pl) * | 2020-05-20 | 2023-09-04 | Univ Jagiellonski | Nowe pochodne 9H-fluorenu lub ich farmaceutycznie dopuszczalne sole |
| CN113189089B (zh) * | 2021-03-19 | 2022-05-17 | 四川轻化工大学 | 一种臭氧检测试剂及其制备装置和制备方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61118352A (ja) * | 1984-10-29 | 1986-06-05 | イー・アール・スクイブ・アンド・サンズ・インコーポレイテツド | アミノ酸エステルおよびアミドレニン抑制剤 |
| US5362912A (en) * | 1989-05-23 | 1994-11-08 | Abbott Laboratories | Process for the preparation of a substituted diaminodiol |
| US5696270A (en) * | 1989-05-23 | 1997-12-09 | Abbott Laboratories | Intermediate for making retroviral protease inhibiting compounds |
| US5387742A (en) * | 1990-06-15 | 1995-02-07 | Scios Nova Inc. | Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease |
| DK0568575T4 (da) * | 1991-01-21 | 2010-12-20 | Elan Pharm Inc | Test og model for Alzheimers sygdom |
| FR2676173B1 (fr) | 1991-05-06 | 1993-08-13 | Oreal | Composition cosmetique contenant un agent alcalinisant sans odeur. |
| DK0620849T3 (da) * | 1992-01-07 | 2003-10-20 | Elan Pharm Inc | Transgene dyremodeller for Alzheimer's sygdom |
| DE4208756A1 (de) | 1992-03-19 | 1993-09-23 | Basf Ag | Diaminoalkane, verfahren zu deren herstellung sowie kraftstoffe und schmierstoffe, enthaltend die diaminoalkane |
| US5604102A (en) * | 1992-04-15 | 1997-02-18 | Athena Neurosciences, Inc. | Methods of screening for β-amyloid peptide production inhibitors |
| US5766846A (en) * | 1992-07-10 | 1998-06-16 | Athena Neurosciences | Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
| US5968942A (en) * | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
| EP1302468B1 (en) * | 1992-12-29 | 2008-12-17 | Abbott Laboratories | Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| DE69426571T2 (de) * | 1993-10-27 | 2001-08-09 | Elan Pharm Inc | TRANSGENE TIERE, DIE APP Allele mit der schwedischen Mutation beherbergen |
| US5877399A (en) * | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
| MX9709874A (es) * | 1995-06-06 | 1998-03-31 | Pfizer | N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN. |
| US6024768A (en) | 1996-07-03 | 2000-02-15 | Hans Schwarzkopf Gmbh & Co. Kg | Diaminoalkane and oxidation colorants |
| JP2001510474A (ja) * | 1997-02-04 | 2001-07-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | カテプシンｄのナノモルの非ペプチド阻害剤 |
| AU8673598A (en) * | 1997-08-01 | 1999-02-22 | University Of Florida | Neuraminidase inhibitors |
| CA2343004A1 (en) | 1998-09-24 | 2000-03-30 | Pharmacia & Upjohn Company | Alzheimer's disease secretase |
| EP1299352B1 (en) * | 2000-06-30 | 2005-12-28 | Elan Pharmaceuticals, Inc. | Compounds to treat alzheimer's disease |
| US6846813B2 (en) * | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
| PE20020276A1 (es) * | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| DE60226729D1 (de) * | 2001-06-01 | 2008-07-03 | Elan Pharm Inc | Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten |
| MXPA04000334A (es) * | 2001-07-11 | 2004-09-28 | Elan Pharm Inc | Compuestos de alquilamida n-(3-amino-2-hidroxi-propil) substituidos. |
| EA200400648A1 (ru) * | 2001-11-08 | 2005-04-28 | Элан Фармасьютикалз, Инк. | N, n'-замещенные производные 1,3-диамино-2-гидроксипропана |
| BR0214736A (pt) * | 2001-12-06 | 2004-11-23 | Elan Pharm Inc | Composto e seus sais farmaceuticamente aceitáveis, composição farmacêutica e método de tratar seres humanos ou animais que sofrem de doenças ou condições |
| WO2004022523A2 (en) * | 2002-09-06 | 2004-03-18 | Elan Pharmaceuticals, Inc. | 1, 3-diamino-2-hydroxypropane prodrug derivatives |
-
2003
- 2003-09-09 UY UY27967A patent/UY27967A1/es not_active Application Discontinuation
- 2003-09-10 MX MXPA05002695A patent/MXPA05002695A/es active IP Right Grant
- 2003-09-10 JP JP2004571986A patent/JP2006504793A/ja active Pending
- 2003-09-10 EA EA200500472A patent/EA009196B1/ru not_active IP Right Cessation
- 2003-09-10 AU AU2003267132A patent/AU2003267132A1/en not_active Abandoned
- 2003-09-10 PE PE2003000914A patent/PE20041079A1/es not_active Application Discontinuation
- 2003-09-10 GE GEAP20038737A patent/GEP20074166B/en unknown
- 2003-09-10 WO PCT/US2003/028503 patent/WO2004024081A2/en not_active Ceased
- 2003-09-10 KR KR1020057004161A patent/KR20060057520A/ko not_active Ceased
- 2003-09-10 TW TW092125081A patent/TWI336320B/zh not_active IP Right Cessation
- 2003-09-10 NZ NZ539095A patent/NZ539095A/en not_active IP Right Cessation
- 2003-09-10 UA UAA200502191A patent/UA84407C2/ru unknown
- 2003-09-10 PL PL376511A patent/PL376511A1/pl not_active Application Discontinuation
- 2003-09-10 US US10/658,959 patent/US7244725B2/en not_active Expired - Fee Related
- 2003-09-10 BR BR0314188-8A patent/BR0314188A/pt not_active IP Right Cessation
- 2003-09-10 AR ARP030103276A patent/AR043679A1/es unknown
- 2003-09-10 EP EP03749607A patent/EP1565443A4/en not_active Withdrawn
- 2003-09-10 OA OA1200500066A patent/OA12919A/en unknown
- 2003-09-10 CA CA002498248A patent/CA2498248A1/en not_active Abandoned
-
2005
- 2005-03-09 IS IS7732A patent/IS7732A/is unknown
- 2005-03-10 NO NO20051239A patent/NO20051239L/no not_active Application Discontinuation
- 2005-03-21 EC EC2005005696A patent/ECSP055696A/es unknown
- 2005-04-06 MA MA28202A patent/MA27472A1/fr unknown
-
2006
- 2006-06-06 US US11/447,789 patent/US7645780B2/en not_active Expired - Fee Related
-
2009
- 2009-11-23 US US12/624,100 patent/US20100145056A1/en not_active Abandoned
-
2010
- 2010-12-08 JP JP2010273586A patent/JP2011084568A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006504793A5 (enExample) | ||
| EP1112251B1 (fr) | Derives d'azetidine, leur preparation et les medicaments les contenant | |
| CN1173948C (zh) | α-取代的芳基磺酰氨基异羟肟酸和制备方法及其组合物 | |
| CN1136314A (zh) | 用作消炎剂的异噁唑啉化合物 | |
| CN1157615A (zh) | 杂环速激肽受体拮抗物 | |
| CZ4994A3 (en) | Pyrrolidine derivatives, process of their preparation and medicaments in which said derivatives are comprised | |
| WO2001064633A1 (fr) | Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation | |
| CN1882587A (zh) | 三环化合物作为甘氨酸转运抑制剂的用途 | |
| CN1041940A (zh) | 哌啶基苯并咪唑类化合物 | |
| CN1174548A (zh) | 用作降胆固醇剂的硫取代的氮杂环丁烷酮类化合物 | |
| JPH03206086A (ja) | 芳香族アミン化合物、その製造方法、およびそれを含む医薬 | |
| LU84070A1 (fr) | Derives phenylcyclobutyliques,leur procede de preparation et leur application therapeutique | |
| WO1994007843A1 (en) | Cyclohexyl amine derivatives and their use as tachykinin antagonists | |
| ZA200607542B (en) | MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles | |
| CA2436526A1 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
| EP1680402A1 (fr) | Derives de n-[[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| JP2008512470A5 (enExample) | ||
| TW201712004A (zh) | 吡唑衍生物或其藥理學上容許之鹽 | |
| EP0734379A1 (fr) | Nouveaux derives de 2-arylalkenyl-azacycloalkanes ligands aux recepteurs sigma, leur procede de preparation et leur application en therapeutique | |
| JP2010506910A5 (enExample) | ||
| JPH08291112A (ja) | アリールアルキル−アミンおよびアミド | |
| JP2007508395A5 (enExample) | ||
| JP2001515509A (ja) | 新規キノリン−およびナフタレンカルボキサミド、医薬組成物およびカルパインの阻害方法 | |
| JP2005513036A (ja) | キノリン誘導体、それらの製造方法、ならびにｓ−ＣＤ２３により媒介される障害の治療におけるそれらの使用 | |
| WO1994002473A1 (fr) | Derives de la n-cycloalkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant |